No Data
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma
Lacklustre Performance Is Driving Pacira BioSciences, Inc.'s (NASDAQ:PCRX) 26% Price Drop
Pacira BioSciences Analyst Ratings
Express News | Pacira Biosciences Inc : Truist Securities Cuts Target Price to $8 From $30
Express News | Pacira Biosciences Inc : Truist Securities Cuts to Sell From Buy